title: Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
abstract: OBJECTIVE
  The aim of this study is to describe recommendations made by clinical pharmacists when co-managing hypertension with physicians.
  
  
  METHODS
  Two family medicine clinics at a major teaching hospital in the mid-western United States.
  
  
  METHODS
  This report details the specific recommendations made by pharmacists during a prospective randomized controlled clinical trial. Patients with uncontrolled hypertension were enrolled in a 9-month intensive pharmacist-physician co-management study. Clinical pharmacists saw patients at baseline, 2, 4, 6, and 8 month visits. Optional visits were allowed between required visits.
  
  
  METHODS
  For this analysis, pharmacist recommendations were grouped. Physician acceptance of the pharmacists' recommendations was also evaluated.
  
  
  RESULTS
  Data from 101 patients were included and analyzed in this study. Changes in drug therapy were recommended 267 times for these 101 patients. Most recommendations for a change in treatment involved adding a new antihypertensive medication (46.4%) or increasing a dose (33.3%). The majority of pharmacist recommendations to modify drug therapy were made at the baseline visit (41.6%), with 76.8% of recommendations made by the 2 month visit. Physicians accepted and implemented 95.9% of the 267 pharmacist recommendations to modify drug therapy. Pharmacists recommended no change in the treatment plan 361 times, most often because the patient's blood pressure (BP) had achieved the goal. Average BP decreased from 153.1+/-10.0/84.9+/-12.0 mmHg (average+/-SD) at baseline to 124.2+/-9.7/74.7+/-9.6 mmHg (P<0.001) at the end of 9 months, with 89.1% (P<0.001) of patients reaching their BP goal.
  
  
  CONCLUSIONS
  Pharmacist recommendations for alterations in drug therapy generally occurred early in the course of the study and were largely to intensify therapy through higher dosages or additional medications. Pharmacist-physician co-management of BP is effective at reducing BP and improving BP control rates.
authors: Division of Clinical and Administrative Pharmacy, Room 527, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
authors: Shannon J
authors: SJ
authors: Von Muenster
authors: Barry L
authors: BL
authors: Carter
authors: Cynthia A
authors: CA
authors: Weber
authors: Michael E
authors: ME
authors: Ernst
authors: Jessica L
authors: JL
authors: Milchak
authors: Jennifer J G
authors: JJ
authors: Steffensmeier
authors: Yinghui
authors: Y
authors: Xu
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006784:Hospitals, Teaching; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007400:Interprofessional Relations; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D010595:Pharmacists; D010607:Pharmacy Service, Hospital; D010820:Physicians; D024382:Professional Role; D011446:Prospective Studies; D014481:United States
chemical_list: D000959:Antihypertensive Agents
references: N Engl J Med. 2001 Aug 16;345(7):479-86
references: 11519501
references: Hypertension. 2003 Dec;42(6):1206-52
references: 14656957
references: Lancet. 2004 Jun 19;363(9426):2022-31
references: 15207952
references: J Clin Hypertens (Greenwich). 2008 Apr;10(4):260-71
references: 18401223
references: J Am Pharm Assoc (Wash). 1996 Jul;NS36(7):443-51
references: 8840744
references: Med Care. 1983 Apr;21(4):435-44
references: 6843196
references: Am J Hosp Pharm. 1979 Jul;36(7):912-5
references: 474579
references: Hypertension. 2005 Jan;45(1):142-61
references: 15611362
references: J Hypertens. 2003 Jun;21(6):1011-53
references: 12777938
references: N Engl J Med. 1998 Dec 31;339(27):1957-63
references: 9869666
references: J Gen Intern Med. 2005 Dec;20(12):1091-6
references: 16423096
references: J Am Pharm Assoc. 1974 Apr;14(4):190-5
references: 4819535
references: Am J Hosp Pharm. 1979 Oct;36(10):1321-5
references: 507073
references: Pharmacotherapy. 2003 Feb;23(2):209-16
references: 12587810
references: Pharmacotherapy. 2002 Dec;22(12):1533-40
references: 12495164
references: Hypertension. 2001 Jan;37(1):12-18
references: 11208750
references: J Am Pharm Assoc (2003). 2004 May-Jun;44(3):337-49
references: 15191244
references: Ann Pharmacother. 2000 Jun;34(6):772-87
references: 10860139
references: J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):31-7
references: 12556651
references: Arch Intern Med. 1981 Oct;141(11):1441-4
references: 7283555
references: Arch Intern Med. 2002 Feb 25;162(4):413-20
references: 11863473
references: Pharmacotherapy. 1997 Jan-Feb;17(1):140-7
references: 9017775
references: Pharmacotherapy. 1997 Nov-Dec;17(6):1274-85
references: 9399611
references: Arch Intern Med. 1984 Jun;144(6):1159-62
references: 6732373
references: Lancet. 1998 Jun 13;351(9118):1755-62
references: 9635947
references: DICP. 1990 Mar;24(3):304-9
references: 2316237
references: J Gen Intern Med. 1998 Nov;13(11):740-5
references: 9824519
references: Circulation. 1973 Nov;48(5):1104-11
references: 4201656
references: Hypertension. 2001 Jan;37(1):19-27
references: 11208751
references: JAMA. 2006 Dec 6;296(21):2563-71
references: 17101639
references: JAMA. 2002 Nov 20;288(19):2421-31
references: 12435255
references: Pharmacotherapy. 2000 Nov;20(11):1384-9
references: 11079287
references: Educ Health (Abingdon). 2003 Jul;16(2):230
references: 14741909
references: Am J Hosp Pharm. 1988 Apr;45(4):824-7
references: 3376965
references: Rev Clin Esp. 2006 Nov;206(10):510-4
references: 17129520
references: Circulation. 1997 Feb 18;95(4):1085-90
references: 9054774
references: Med Care. 2006 Jul;44(7):646-57
references: 16799359
references: Can J Cardiol. 2005 May 15;21(7):589-93
references: 15940357
references: Hypertension. 2007 Jan;49(1):69-75
references: 17159087